{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544418753314432.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.hepres.2004.08.003"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1386--634(6()04)00213--X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1386--634(6()04)00213--X?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"15588781"}}],"dc:title":[{"@value":"Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey"}],"description":[{"notation":[{"@value":"BACKGROUND:: The low incidence of fulminant hepatitis (FH) makes it difficult to accurately assess its viral etiology and clinical characteristics. Additionally, the therapeutic options for FH have markedly changed over the years because of the substantial introduction of living-donor liver transplantation. AIM:: To analyze and summarize a large-scale national survey on FH in the pretransplantation era in Japan. METHOD:: An analysis of answers to an annual questionnaire sent to 313 centers for liver diseases in Japan between 1983 and 1997. RESULTS:: During the study period, 1309 patients were registered as having fulminant hepatitis. The causes of FH were: hepatitis A virus (HAV) in 7.8%, hepatitis B virus (HBV) in 23.8%, probable HBV (positive for serum HBs antigen or HBV DNA and negative for the IgM anti-hepatitis B core antibody) in 13.8%, non-A, non-B hepatitis in 29.3%, drug-induced in 9.3, and unknown in 16.0% of these patients. The incidence of HBV-related cases did not decrease during the study period. The acute type had a significantly better prognosis than the subacute type (survival rate, 36.2% versus 15.3%, P0.001). The survival rate tended to improve in the third 5-year period for the acute type (28.6% [1983-1987] versus 43.3% [1994-1997]), but not for the subacute type (15.4% versus 12.3%). CONCLUSIONS:: HBV remains a major cause of fulminant hepatitis in Japan. New therapeutic modalities, including liver transplantation, are required for improving the prognosis, in particular, for the subacute type of fulminant hepatitis."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544418753314560","@type":"Researcher","foaf:name":[{"@value":"S SATO"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13866346"}],"prism:publicationName":[{"@value":"Hepatology Research"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2004-11","prism:volume":"30","prism:number":"3","prism:startingPage":"155","prism:endingPage":"161"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1386--634(6()04)00213--X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1386--634(6()04)00213--X?httpAccept=text/plain"}],"createdAt":"2004-09-29","modifiedAt":"2019-02-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004235757644928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Etiology and prognosis of fulminant hepatitis and late‐onset hepatic failure in <scp>J</scp>apan: Summary of the annual nationwide survey between 2004 and 2009"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710588048384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Changing etiologies and outcomes of acute liver failure: A perspective from Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864782750464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092806370560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Multicenter study on the consciousness‐regaining effect of a newly developed artificial liver support system in acute liver failure: An on‐line continuous hemodiafiltration system"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660454206208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204791787520","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Validity study of DDW-J2004 scoring scale for drug-induced liver injury"},{"@language":"ja","@value":"ＤＤＷ‐Ｊ２００４薬物性肝障害ワークショップのスコアリングに関するｖａｌｉｄｉｔｙ　ｓｔｕｄｙ"},{"@value":"DDW-J2004薬物性肝障害ワークショップのスコアリングに関するvalidity study"},{"@language":"ja-Kana","@value":"DDW J2004 ヤクブツセイ カン ショウガイ ワークショップ ノ スコアリング ニ カンスル validity study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204795667072","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"劇症肝炎：わが国における問題点"},{"@language":"en","@value":"Fulminant hepatitis: Recent problems in Japan"},{"@language":"ja-Kana","@value":"ゲキショウ カンエン ワガクニ ニ オケル モンダイテン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204875808768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Isoniazid-induced Acute Liver Failure during Preventive Therapy for Latent Tuberculosis Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680174036864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"急性肝炎におけるVirtual touch quantificationの臨床的意義"},{"@language":"en","@value":"Clinical significance of Virtual touch quantification in acute hepatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390867819748129408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Acute Liver Failure Caused by Isoniazid during Preventive Treatment for Latent Tuberculosis: A Rare Autopsy Case Report"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.hepres.2004.08.003"},{"@type":"OPENAIRE","@value":"doi_dedup___::fe2f34a447226391fbcae056d0192893"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2012.01105.x_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.2957/kanzo.48.219_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.4720-24_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.1111/j.1440-1746.2010.06574.x_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.2957/kanzo.50.497_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.1111/hepr.13983_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.54.3669_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.1111/hepr.13557_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.1111/hepr.12093_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"},{"@type":"CROSSREF","@value":"10.3179/jjmu.jjmu.r.38_references_DOI_V0tNvUkhcPXG1k0gNT6wqpEpXZL"}]}